-
Product Insights
Double Stranded RNA Specific Adenosine Deaminase – Drugs In Development, 2023
Global Markets Direct’s Double Stranded RNA Specific Adenosine Deaminase provides in depth analysis on Double Stranded RNA Specific Adenosine Deaminase targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved...
-
Product Insights
Interferon Induced Double Stranded RNA Activated Protein Kinase – Drugs In Development, 2023
Global Markets Direct’s Interferon Induced Double Stranded RNA Activated Protein Kinase provides in depth analysis on Interferon Induced Double Stranded RNA Activated Protein Kinase targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview...
-
Product Insights
NewLikelihood of Approval Analysis for Togaviridae Infections
Overview How likely is it that the drugs in Togaviridae Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Togaviridae Infections Overview The Togaviridae is a family of enveloped, single-stranded, plus-strand...
-
Product Insights
NewLikelihood of Approval Analysis for Poxviridae Infections
Overview How likely is it that the drugs in Poxviridae Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Poxviridae Infections Overview Poxviridae is a family of double-stranded DNA viruses. Poxviruses...
-
Product Insights
NewLikelihood of Approval Analysis for Picornaviridae Infections
Overview How likely is it that the drugs in Picornaviridae Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Picornaviridae Infections Overview The family PICORNAVIRIDAE comprises five genera, namely, enteroviruses, rhinoviruses,...
-
Product Insights
NewLikelihood of Approval Analysis for Rhabdoviridae Infections
Overview How likely is it that the drugs in Rhabdoviridae Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rhabdoviridae Infections Overview The family Rhabdoviridae are negatively stranded RNA viruses consisting...
-
Product Insights
NewLikelihood of Approval Analysis for Lentivirus Infections
Overview How likely is it that the drugs in Lentivirus Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lentivirus Infections Overview Lentiviruses are a subgroup of retroviruses, a family of...
-
Product Insights
NewLikelihood of Approval Analysis for Lyssavirus infections
Overview How likely is it that the drugs in Lyssavirus infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lyssavirus infections Overview The infections caused by a group of lyssaviruses are...
-
Product Insights
NewLikelihood of Approval Analysis for Pneumovirus Infections
Overview How likely is it that the drugs in Pneumovirus Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pneumovirus Infections Overview Pneumoviridae is a family of negative-strand RNA viruses in...
-
Product Insights
NewLikelihood of Approval Analysis for Hepacivirus Infections
Overview How likely is it that the drugs in Hepacivirus Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hepacivirus Infections Overview Hepacivirus infections are caused by a genus of positive-strand...